Name: UMIN ID:
Unique ID issued by UMIN | UMIN000010298 |
---|---|
Receipt number | R000011812 |
Scientific Title | A Phase III Study Comparing Irinotecan and Cisplatin with Etoposide and Cisplatin for Adjuvant Chemotherapy of Completely Resected Pulmonary High-grade Neuroendocrine Carcinoma (JCOG1205/1206, HGNEC-EP/IP-P3) |
Date of disclosure of the study information | 2013/03/25 |
Last modified on | 2022/08/30 17:22:34 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/03/22 14:06:48 | ||
2 | Update | 2014/04/18 11:41:13 | Organization Organization Division name Division name Address Address TEL Institutions |
|
3 | Update | 2014/12/18 11:05:15 | Institutions |
|
4 | Update | 2016/04/12 10:30:13 | Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2016/04/12 10:44:34 | Name of primary person or sponsor Organization Organization Organization Institutions |
|
6 | Update | 2016/04/12 10:45:06 | Last follow-up date |
|
7 | Update | 2021/01/05 16:27:17 | Recruitment status Date of IRB |
|
8 | Update | 2022/08/30 17:22:34 | Recruitment status Date of IRB |